Vimarsana
Biggest News Aggregation in the World

Page 18 - Target Advisor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Target Advisor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Target Advisor Today - Breaking & Trending Today

Cintas (NASDAQ:CTAS) PT Raised to $362.00 at Morgan Stanley - Vimarsana News

Cintas (NASDAQ:CTAS) PT Raised to $362.00 at Morgan Stanley

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

Oportun Financial (NASDAQ:OPRT) Price Target Cut to $17.00 by Analysts at JMP Securities - Vimarsana News

Oportun Financial (NASDAQ:OPRT) Price Target Cut to $17.00 by Analysts at JMP Securities

Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.

HCA Healthcare (NYSE:HCA) PT Lowered to $212.00 - Vimarsana News

HCA Healthcare (NYSE:HCA) PT Lowered to $212.00

HCA Healthcare (NYSE:HCA – Get Rating) had its price target lowered by SVB Leerink from $273.00 to $212.00 in a research report issued on Friday, Stock Target Advisor reports. The firm presently has an “outperform” rating on the stock. SVB Leerink’s target price would suggest a potential upside of 23.54% from the stock’s previous close. […]

Insmed (NASDAQ:INSM) Price Target Lowered to $41.00 at Morgan Stanley - Vimarsana News

Insmed (NASDAQ:INSM) Price Target Lowered to $41.00 at Morgan Stanley

Insmed (NASDAQ:INSM – Get Rating) had its price objective cut by equities research analysts at Morgan Stanley from $46.00 to $41.00 in a research report issued on Friday, Stock Target Advisor reports. The firm presently has an “overweight” rating on the biopharmaceutical company’s stock. Morgan Stanley’s target price suggests a potential upside of 77.26% from […]

Visteon (NYSE:VC) Price Target Cut to $91.00 - Vimarsana News

Visteon (NYSE:VC) Price Target Cut to $91.00

Visteon (NYSE:VC – Get Rating) had its target price decreased by stock analysts at Morgan Stanley from $93.00 to $91.00 in a research note issued to investors on Thursday, Stock Target Advisor reports. Morgan Stanley’s price objective would suggest a potential downside of 15.66% from the stock’s current price. Separately, StockNews.com started coverage on shares […]